Cytokine gene polymorphisms in acquired bone marrow failure

American Journal of Hematology

Volumn 82, Issue 8, 2007, Pages 721-724

  Gidvani, Vinod ^a   Ramkissoon, Shakti ^b   Sloand, Elaine M ^b   Young, Neal S ^b  

^a WILFORD HALL MEDICAL CENTER   (United States)

^b NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 1; INTERLEUKIN 6; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ADULT; AGED; ALLELE; APLASTIC ANEMIA; ARTICLE; AUTOIMMUNE DISEASE; BONE MARROW DEPRESSION; CHILD; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE PREDISPOSITION; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; HEMATOPOIETIC STEM CELL; HUMAN; INTRON; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; TANDEM REPEAT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BONE MARROW DISEASES; CHILD; CHILD, PRESCHOOL; CYTOKINES; FEMALE; HUMANS; INTRONS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC;

EID: 34547655804     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.20881     Document Type: Article

References (21)

1. Young NS. Acquired aplastic anemia. Ann Int Med 2002;136:534-546.
2. Pravica V, Perrey C, Stevens A, et al. A single nucleotide polymorphism in the first intron of the human IFN-γ gene: Absolute correlation with a polymorphic CA microsatellite marker of high IFN-γ production. Human Immunol 2000;61:863-866.
3. Tseng LH, Chen PJ, Lin MT, et al. Simultaneous genotyping of single nucleotide polymorphisms in the IL-6, IL-10 TNF-α and TNFβ genes. Tissue Antigens 2002;59:280-286.
4. Tarlow JK, Blakemore AI, Lennard A, et al. Polymorphism in human IL-1 receptor antagonist gene intron 2 is caused by variable numbers of an 86-bp tandem repeat. Hum Genet 1993;91: 403-404.
5. Caserta TM, Knisley AA, Tan FK, et al. Genotypic analysis of the TGF β-509 allele in patients with systemic lupus erythematosus and Sjogren's syndrome. Ann de Genetique 2004;47:359-363.
6. Cozen W, Gill PS, Ingles SA, et al. IL-6 levels and genotype are associated with risk of young adult Hodgkin lymphoma. Blood 2004:103:3216-3221.
7. Cordano P, Lake A, Shield L, et al. Effect of IL-6 promoter polymorphism on incidence and outcome in Hodgkin's lymphoma. Br J Hematol 2005;128:493-495.
8. Brown MJ, Burton PR, Horsburgh T, et al. The role of cytokine gene polymorphisms in the pathogenesis of abdominal aortic aneurysms: A case-control study. J Vasc Surg 2003;37:999-1005.
9. Demeter J, Messer G, Schrezenmeier H. Clinical relevance of TNF-α promoter/enhancer polymorphism in patients with aplastic anemia. Ann Hematol 2002;81:566-569.
10. Havranek E, Howell WM, Fussell HM, et al. An interleukin-10 promoter polymorphism may influence tumor development in renal cell carcinoma. J Urol 2005;173:709-712.
11. Howell WM, Turner SJ, Theaker JM, et al. Cytokine gene single nucleotide polymorphisms and susceptibility to and prognosis in cutaneous malignant melanoma. Eur J Immunogen 2003;30:409-414.
12. 1, interleukin-10, and interferon-γ polymorphisms in patients with alcoholic chronic pancreatitis. Alcohol 2004;32:19-24.
13. Ben-Ari Z, Mor E, Papo O, et al. Cytokine gene polymorphisms in patients infected with hepatitis B virus. Am J Gastroenterol 2003;98:144-150.
14. Rider LG, Artlett CM, Foster CB, et al. Polymorphisms in the IL-1 receptor antagonist gene VNTR are possible risk factors for juvenile idiopathic inflammatory myopathies. Clin Exp Immunol 2000;121:47-52.
15. Fang XM, Schroder S, Hoeft A, et al. Comparison of two polymorphisms of the interleukin-1 gene family; interleukin-1 receptor antagonist polymorphism contributes to severe sepsis. Crit Care Med 1999;27:1330-1334.
16. Silverman ES, Palmer LJ, Subramaniam V, et al. Transforming growth factor-β1 promoter polymorphism C-509T is associated with asthma. Am J Respir Crit Care Med 2004;169:214-219.
17. Kook H, Lee HC, Kim HJ, et al. Bone marrow (bm) mrna expression and serum concentration of interferon (ifn)-y and tumor necrosis factor (tnf)-a in patients with aplastic anemia (aa). Blood 1997; 90(Suppl 1):16b.
18. Sloand E, Kim S, Maciejewski JP, et al. Intracellular interferon-γ in circulating and marrow T cells detected by flow cytometry and the response to immunosuppressive therapy in patients with aplastic anemia. Blood 2002; 100:1185-1191.
19. Zeng W, Kajigaya S, Chen G, et al. Transcript profile of CD4+ and CD8+ T cells from the bone marrow of acquired aplastic anemia patients. Exp Hematol 2004;32:806-814.
20. Dufour C, Capasso M, Svahn J. Homozygosis for (12) CA repeats in the first intron of the human IFN-γ gene is significantly associated with the risk of aplastic anaemia in Caucasian population. Br J Hematol 2004;126:682-685.
21. Rizzo S, Killick SB, Patel S, et al. Reduced TGF-β1 in patients with aplastic anaemia in vivo and in vitro. Br J Hematol 1999;107:797-803.